Loading

From Clinical to Commercial: How Strategic Partnerships Can Accelerate Development and Enable Launch Excellence

June 18, 2025
Breakout Session
Cell and Gene Therapy and Genome Editing
251
In the rapidly evolving landscape of cell and gene therapy, the journey from clinical development to commercial launch presents unique challenges and opportunities. This session will provide attendees with actionable insights and a better understanding of how strategic collaborations can enable innovation to overcome barriers and position breakthrough therapies for commercial success. Join us as we discuss proven strategies to navigate the complexities of the cell and gene therapy landscape. Sponsored by: Cencora
Moderator
Kevin Chinn
Vice President and Head of the Cell & Gene Therapy Service Line
Cencora
Speakers
Mathias Kroll, PhD,MBA,MSc
Chief Business Officer
Cynata
Sare Largay
Chief Officer Biomedicine North America
Miltenyi
Brad Martin
Vice President, Head of Market Access and Trade
Neurotech Pharmaceuticals
Laurel Todd
VP, US Market Access & Policy
Iovance

Sponsored by:

cencora

Back to Session List

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS